By Mohan B. Jain
The shadow of cancer looms large in India. According to the latest estimates released by the World Health Organisation’s International Agency for Research on Cancer (IARC), India reported more than 14.13 lakh new cancer cases and 9.16 lakh deaths in 2022.
Breast, oral and cervical cancer accounted for nearly one third of the new cases in India and cancer cases among women marginally outnumbered those in men. Despite the daunting figures, there is hope, fuelled by the unrelenting efforts to push back against the disease.
The challenges to cancer prevention are multifaceted. A lack of awareness often leads to late diagnosis, significantly impacting survival rates. Infrastructure limitations often result in many people travelling to other cities for specialized care, while the cost of treatment adds another layer of hardship.
Early detection remains our most potent weapon. Initiatives such as the National Cancer Screening Programme and community outreach programs are raising awareness, encouraging self-examinations and regular check-ups. Advancements in screening technologies can significantly help in these efforts to detect cancer at its most treatable stage.
The one-size-fits-all approach to cancer is fading. By using precision medicine, treatment can be tailored to individuals based on their genetic profiles, resulting in favourable patient outcomes. Researchers are actively contributing to this field, developing targeted therapies and paving the way for more effective and individualized treatment plans.
Innovation in cancer treatment is challenging the norm. From immunotherapy’s potential to harnessing AI in drug discovery, scientists and pharma companies are at the forefront of ground breaking research. Their efforts hold immense promise for the future of cancer treatment.
However, no single entity can conquer the complex disease alone. Pharma companies, researchers, policymakers, and patient advocacy groups must all work together to deal with cancer head-on. Dedicated research institutions fostering collaborations are also helping accelerate the progress.
Finally, accessibility remains the cornerstone of hope. Making cancer care accessible and affordable is paramount. Most recently, the government’s plans for a national cervical cancer vaccination drive announced in the Union Budget will also have an immensely positive impact. The government’s Ayushman Bharat scheme has also allowed the nation to take large strides in addressing cancer, but more can be done. From expanding insurance coverage to establishing affordable treatment centres, fostering public-private partnerships can be crucial in ensuring equitable access for all.
While the disease will continue to linger, our unwavering efforts can help in creating a path towards a brighter future. By investing in programs that enable early detection, foster innovation and help bridge the care gap, we can push back the tide of cancer, paving the way for a healthier tomorrow.
(The author is the Managing Director, Naprod Life Sciences. Views expressed are personal and do not reflect the official position or policy of the FinancialExpress.com.)
